🔎 Trials Near Me

Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › New York › New York City

Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in New York City, NY

7 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

RecruitingPhase 2
  • Site Number - 1605, New York
  • Site Number - 1627, New York
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07032662

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

RecruitingPhase 3
  • Hospital for Special Surgery - Site Number : 8400041, New York
  • Columbia University Irving Medical Center- Site Number : 8400003, New York
  • Lenox Hill Hospital- Site Number : 8400051, New York
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

RecruitingPhase 1
  • TG Therapeutics Investigational Trial Site, New York
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06680037

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

RecruitingPhase 3
  • GC2402 Study Site 110, New York
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07540221

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

RecruitingPhase 3
  • Clinical Study Site, New York
  • Clinical Study Site, New York
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

RecruitingPhase 1
  • Columbia University Irving Medical Center, New York
Ages 18 to 75 · All sexes · Updated Aug 14, 2026 · NCT07304154

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

RecruitingPhase 3
  • NYU Langone Health, New York
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351

Chronic Inflammatory Demyelinating Polyradiculoneuropathy trials in other cities

Other studies in New York City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.